In this multicentre randomised trial from USA, the safety and efficacy of unilobar endobronchial valve therapy in patients with heterogeneous emphysema was compared with usual care.

In terms of effectiveness, the co-primary outcomes were percentage change in FEV₁ and distance on the 6 min walk test. In terms of safety, the primary outcome was the difference in complication rate, using a composite of six …